BioNTech reveals a solution to Vaccine accessibility all over the world
BioNTech is most recently known for its mRNA COVID-19 vaccine which was approved in December 2020. This great accomplishment, however, was challenged by the obstacle of limited global manufacturing. Currently, vaccines are only being manufactured … Read more